Nutcracker Syndrome (a Delphi consensus).


Journal

Journal of vascular surgery. Venous and lymphatic disorders
ISSN: 2213-3348
Titre abrégé: J Vasc Surg Venous Lymphat Disord
Pays: United States
ID NLM: 101607771

Informations de publication

Date de publication:
01 Oct 2024
Historique:
received: 28 04 2024
revised: 27 08 2024
accepted: 10 09 2024
medline: 4 10 2024
pubmed: 4 10 2024
entrez: 3 10 2024
Statut: aheadofprint

Résumé

Nutcracker syndrome describes the symptomatic compression of the left renal vein between the aorta and superior mesenteric artery. Whereas asymptomatic compression is a common radiological finding, patients with nutcracker syndrome can report a range of symptoms. There are no specific diagnostic criteria and interventions include a range of open surgical and endovascular procedures. Therefore, we wished to develop an international consensus document covering aspects of diagnosis, management, and follow-up for patients with nutcracker syndrome. A three-stage modified Delphi consensus was performed. A steering committee developed 37 statements covering three categories for patients with nutcracker syndrome: diagnosis, management and follow-up. These statements were reported individually by 20 international experts in the management of venous disease, using a five-point Likert scale. Consensus was defined if ≥70% of respondents rated the statement between 1 or 2 (agreement) and between 4 or 5 (disagreement). Those statements without consensus were recirculated in a second round of voting. A third round of the questionnaire was performed with 14 additional statements to clarify diagnostic values of nutcracker syndrome. Responses were achieved by 20 of 20 (100%) experts in round one and 17 of 20 (85%) in round two. Initial consensus was reached in 24 of 37 statements (65%) spread over all categories. Round two achieved a further consensus on five out of ten statements (50%). No categories reported consensus on all statements. In round two consensus was reached in the category of Follow-up (4/5 statements, 80%). The final round reached consensus on 5 out of 14 statements (36%). Experts agreed that imaging is obligated to confirm NCS. Experts did not agree on specific diagnostic cut-off values. There was a consensus that the first choice of operative treatment is left renal vein transposition and that the risk of stent migration outweighs the advantages of a percutaneous procedure. Consensus was achieved on most statements concerning the assessment and management of nutcracker syndrome. This Delphi consensus identified those areas in which further research is needed, such as anti-platelet therapy, endovascular treatment and renal autotransplantation. A rare disease registry to improve data and reports of patient outcomes is warranted.

Identifiants

pubmed: 39362632
pii: S2213-333X(24)00366-4
doi: 10.1016/j.jvsv.2024.101970
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101970

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Floor Heilijgers (F)

Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.

Peter Gloviczki (P)

Devision of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.

Gerry O'Sullivan (G)

Department of Interventional Radiology, Galway University Hospital, Galway, Ireland.

Bertrand Chavent (B)

Department of Vascular Surgery, Clinique Générale, Annecy, France.

Efthymios D Avgerinos (ED)

Department of Vascular Surgery, Athens Medical Center, University of Athens, Athens, Greece.

Karem Harth (K)

Department of Vascular Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve, Ohio, USA.

Stephen A Black (SA)

Department of Vascular Surgery, Ashtead Hospital, Ashtead, United Kingdom.

Young M Erben (YM)

Devision of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, Florida, USA.

Joris I Rotmans (JI)

Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Toby Richards (T)

Department of Surgery, School of Health, Sport & Bioscience University of East London.

Rabih A Chaer (RA)

Institute of Clinic Trials and Methodology, University College London, United Kingdom.

Laurencia Villalba (L)

Department of Vascular Surgery, Wollongong Hospital, Wollongong, New South Wales, Australia.

Arjun Jayaraj (A)

Department of Vascular Surgery, The Rane Center for Venous and Lymphatic Disorders, Jackson, Mississippi, USA.

Rafael D Malgor (RD)

Department of Vascular Surgery, University of Colorado Anschutz Medical Center, Aurora, Colorado, USA.

Ramesh K Tripathi (RK)

Department of Vascular Surgery, University of Queensland, Brisbane, Queensland, Australia.

Anahita Dua (A)

Department of Vascular Surgery, Massachusetts General Hospital and Harvard University, Boston, Massachusetts, USA.

Erin Murphy (E)

Department of Vascular Surgery, Atrium Health Sanger Heart and Vascular Institute, Charlotte, North Carolina, USA.

Simon Rinckenbach (S)

Department of Vascular and Endovascular Surgery, University of Franche Comté, Besançon, France.

Suresh Vedantham (S)

Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.

Jaap F Hamming (JF)

Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.

Joost R van der Vorst (JR)

Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: j.r.van_der_vorst@lumc.nl.

Classifications MeSH